Search for other papers by Katarzyna Wyskida in
Google Scholar
PubMed
Search for other papers by Grzegorz Franik in
Google Scholar
PubMed
Search for other papers by Tomasz Wikarek in
Google Scholar
PubMed
Search for other papers by Aleksander Owczarek in
Google Scholar
PubMed
Search for other papers by Alham Delroba in
Google Scholar
PubMed
Search for other papers by Jerzy Chudek in
Google Scholar
PubMed
Search for other papers by Jerzy Sikora in
Google Scholar
PubMed
Search for other papers by Magdalena Olszanecka-Glinianowicz in
Google Scholar
PubMed
mass index (BMI) during the 3-month period before the study. Patients diagnosed with polycystic ovary syndrome (PCOS), Cushing’s syndrome, thyroid dysfunctions, androgen-secreting tumor, and enzyme deficiency (21-hydroxylase in particular), decreased
Search for other papers by Yali Cheng in
Google Scholar
PubMed
Search for other papers by Qiaoying Lv in
Google Scholar
PubMed
Search for other papers by Bingying Xie in
Google Scholar
PubMed
Search for other papers by Bingyi Yang in
Google Scholar
PubMed
Search for other papers by Weiwei Shan in
Google Scholar
PubMed
Search for other papers by Chengcheng Ning in
Google Scholar
PubMed
Search for other papers by Bing Li in
Google Scholar
PubMed
Search for other papers by Liying Xie in
Google Scholar
PubMed
Search for other papers by Chao Gu in
Google Scholar
PubMed
Search for other papers by Xuezhen Luo in
Google Scholar
PubMed
Search for other papers by Xiaojun Chen in
Google Scholar
PubMed
Search for other papers by Qin Zhu in
Google Scholar
PubMed
( 17 ), type 2 diabetes mellitus ( 18 ) and polycystic ovary syndrome (PCOS) ( 10 ), is the risk factor for EC. A prospective cohort study notes that ‘insulin resistance/metabolic syndrome,’ ‘steroids,’ and ‘inflammation’ factors are the three risk
Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Search for other papers by Davoud Jafari-Gharabaghlou in
Google Scholar
PubMed
Search for other papers by Mostafa Vaghari-Tabari in
Google Scholar
PubMed
Search for other papers by Hajar Oghbaei in
Google Scholar
PubMed
Search for other papers by Laura Lotz in
Google Scholar
PubMed
Search for other papers by Reza Zarezadeh in
Google Scholar
PubMed
Search for other papers by Yeganeh Rastgar Rezaei in
Google Scholar
PubMed
Search for other papers by Mahnaz Ranjkesh in
Google Scholar
PubMed
Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
Search for other papers by Mohammad Nouri in
Google Scholar
PubMed
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Search for other papers by Amir Fattahi in
Google Scholar
PubMed
Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Search for other papers by Saba Nikanfar in
Google Scholar
PubMed
Search for other papers by Ralf Dittrich in
Google Scholar
PubMed
well documented that obesity or excess fat can negatively influence female fertility and ovarian function such as what we see in obese women with polycystic ovary syndrome (PCOS) ( 10 , 11 ). The role of adipokines has also been shown in embryo
Search for other papers by Nancy J Olsen in
Google Scholar
PubMed
Search for other papers by Ann L Benko in
Google Scholar
PubMed
Search for other papers by William J Kovacs in
Google Scholar
PubMed
-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome . Journal of Clinical Endocrinology and Metabolism 2002 87 161 – 165 . ( doi:10.1210/jcem.87.1.8137 ). 32 Olsen NJ Li Q-Z Quan J Wang L Mutwally A
Search for other papers by M Boering in
Google Scholar
PubMed
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Search for other papers by P R van Dijk in
Google Scholar
PubMed
Langerhans Medical Research group, Zwolle, The Netherlands
Search for other papers by S J J Logtenberg in
Google Scholar
PubMed
Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by K H Groenier in
Google Scholar
PubMed
Search for other papers by B H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by R O B Gans in
Google Scholar
PubMed
Langerhans Medical Research group, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by N Kleefstra in
Google Scholar
PubMed
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by H J G Bilo in
Google Scholar
PubMed
treatment withdrew informed consent shortly after implantation of the insulin pump. As a result, 23 patients completed the follow-up period ( 23 ). For the current analysis, patients with a known history of polycystic ovary syndrome (PCOS), hirsutism
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Paulina Tomczuk-Bobik in
Google Scholar
PubMed
Search for other papers by Anna Beata Popławska-Kita in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed
Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Search for other papers by Łukasz Żukowski in
Google Scholar
PubMed
Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Search for other papers by Monika Zbucka-Krętowska in
Google Scholar
PubMed
Search for other papers by Marcin Adamski in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Białystok, Poland
Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
indicated for ovarian cancer), polycystic ovarian syndrome (two women), pregnancy (two women), breastfeeding (one woman), use of hormonal contraception (three women), and history of previous RAI (two women), radiotherapy, or other medical treatment or
Search for other papers by Min Li in
Google Scholar
PubMed
Search for other papers by Ying Chen in
Google Scholar
PubMed
Search for other papers by Jingjing Jiang in
Google Scholar
PubMed
Search for other papers by Yan Lu in
Google Scholar
PubMed
Search for other papers by Zhiyi Song in
Google Scholar
PubMed
Search for other papers by Shengjie Zhang in
Google Scholar
PubMed
Search for other papers by Chao Sun in
Google Scholar
PubMed
Search for other papers by Hao Ying in
Google Scholar
PubMed
Search for other papers by Xiaofang Fan in
Google Scholar
PubMed
Search for other papers by Yuping Song in
Google Scholar
PubMed
Search for other papers by Jialin Yang in
Google Scholar
PubMed
Search for other papers by Lin Zhao in
Google Scholar
PubMed
human cohorts revealed that Nrg4 levels were increased in patients with prediabetes, newly diagnosed diabetes, gestational diabetes or polycystic ovary syndrome, suggesting Nrg4 concentrations were associated with the development and progression of
Search for other papers by Chun-feng Lu in
Google Scholar
PubMed
Search for other papers by Xiao-qin Ge in
Google Scholar
PubMed
Search for other papers by Yan Wang in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Dong-mei Zhang in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Wang-shu Liu in
Google Scholar
PubMed
Search for other papers by Min Su in
Google Scholar
PubMed
complications. Multiple studies have revealed that serum ADA levels are associated with IR in patients with T2D ( 19 ) and in patients with polycystic ovary syndrome ( 20 ). The underlying mechanism may be that adenosine, the substrate of ADA, can promote
Search for other papers by A Bergougnoux in
Google Scholar
PubMed
INSERM Unité 1203 (DEFE), Université de Montpellier, Montpellier, France
Search for other papers by L Gaspari in
Google Scholar
PubMed
Search for other papers by M Soleirol in
Google Scholar
PubMed
Search for other papers by N Servant in
Google Scholar
PubMed
Search for other papers by S Soskin in
Google Scholar
PubMed
Search for other papers by S Rossignol in
Google Scholar
PubMed
Search for other papers by K Wagner-Mahler in
Google Scholar
PubMed
Search for other papers by J Bertherat in
Google Scholar
PubMed
Search for other papers by C Sultan in
Google Scholar
PubMed
Search for other papers by N Kalfa in
Google Scholar
PubMed
Département d'Endocrinologie et de Gynécologie Pédiatrique, Hôpital Arnaud de Villeneuve, Université de Montpellier, Montpellier, France
INSERM Unité 1203 (DEFE), Université de Montpellier, Montpellier, France
Search for other papers by F Paris in
Google Scholar
PubMed
hyperandrogenism warrant investigations to rule out an adrenal or ovarian disorder, particularly polycystic ovary syndrome and nonclassical congenital adrenal hyperplasia ( 2 , 3 ). In few patients, the clinical expression of hyperandrogenism is more severe with
Search for other papers by Martijn J J Finken in
Google Scholar
PubMed
Search for other papers by Aleid J G Wirix in
Google Scholar
PubMed
Search for other papers by Ines A von Rosenstiel-Jadoul in
Google Scholar
PubMed
Search for other papers by Bibian van der Voorn in
Google Scholar
PubMed
Search for other papers by Mai J M Chinapaw in
Google Scholar
PubMed
Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed
Search for other papers by Joana E Kist-van Holthe in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Search for other papers by Joost Rotteveel in
Google Scholar
PubMed
.2337/db08-0094 ) 33 Wu C Wei K Jiang Z . 5Alpha-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis . Reproductive Biology and Endocrinology 2017 15 21. ( https://doi.org/10.1186/s12958